Life Members · 1/9/2017 · Cancer Medicine and Immunology, The University of Texas M. D....

Life Members

Life Members & Contact

Bharat B. AGGARWAL, Ph.D. (U.C., Berkeley)

Rtired

Founding Director, Anti-inflammation Research Institute,

San Diego, California; USA

Formerly, Professor of Experimental Therapeutics,

Cancer Medicine and Immunology,

The University of Texas M. D. Anderson Cancer Center,

Houston, Texas

Phone: 832-754-0059; Email: [email protected]

Ram P. AGARWAL, Ph.D.

Professor

University of Miami Medical Center

Miami, FL

[email protected]

Krishna C. AGRAWAL, Ph.D. (Deceased)

Regents Professor and Chairman

Department of Pharmacology

Tulane University School of Medicine

New Orleans, LA 70112

Shrikant ANANT, Ph.D.

Professor of Molecular and Integrative Physiology and

Surgery

University of Kansas Medical Center

Kansas City, Kansas

[email protected]

Praveen R. ARANY, DDS, Ph.D. Assistant Professor of Oral Biology

University at Buffalo School of Dental medicine

University at Buffalo State University of New York

Buffalo, NY 14214

E-mail: [email protected]

Thiru ARUMUGAM, Ph.D.

Senior Research Scientist

Department of Cancer Biology

UT MD Anderson Cancer Center, Houston, TX

[email protected];

[email protected]

Shilpi ARORA, Ph.D.

Scientist

Constellation Pharmaceuticals

Boston, MA

[email protected]

Shubha BAGRODIA, Ph.D.

Scientist

Pfizer

San Diego, CA

[email protected]

Research Interest&

Hobbies

Bharat B. AGGARWAL, Ph.D. (U.C., Berkeley)-

inflammation Research Institute,

Professor of Experimental Therapeutics,

The University of Texas M. D. Anderson Cancer Center,

[email protected]

Inflammation and cancer,

cytokines, NF-kβ

, Ph.D. (Deceased)

Professor of Molecular and Integrative Physiology and

Interest in understanding

the mechanisms that

regulate gene expression at

the posttranscriptional

levels of mRNA stability

and translation during

tumorigenesis

University at Buffalo School of Dental medicine

University at Buffalo State University of New York

Therapeutic uses of lasers

and light, particularly in

wound healing and tooth

regeneration.

UT MD Anderson Cancer Center, Houston, TX-77030

Research Interests:

Pancreatic Cancer,

Chemoresistance,

Bioinformatics

Hobbies: Reading, Music

Cancer genetics

Hamid BAND, M.D., Ph.D.

Elizabeth Bruce Professor of Cancer Research at Eppley

Institute, and associate director of translational research at

the Fred & Pamela Buffett Cancer Center

University of Nebraska Medical Center

Omaha, NE

[email protected]

Regulation of tyrosine

kinase-mediated cell

signaling with the long-

term goal of developing

targeted therapeutics and

early

diagnostic/prognostic

markers for cancer

Vimla BAND, Ph.D.

Ardith & Anna Von Housen Professor

Chair, Department of Genetics, Cell Biology & Anatomy

Associate Director of Center for Breast Cancer Research

Fred & Pamela Buffett Cancer Center


Omaha, NE

[email protected]

Delineate molecular

mechanisms of early steps

in transformation of

mammary epithelial cells

with the goal of

identifying novel

molecular

diagnostic/prognostic

markers and potential

therapy targets of breast

cancers

Prashant BAVI, M.D.

Postdoctoral Fellow

Dept Of Human Cancer Genomic Research

[email protected];

[email protected]

Website: http://www.linkedin.com/in/prashantbavi

Research Interests

Oncopathology: Colorectal

Cancer and Thyroid

Cancer,

validation of biomarkers,

improving efficacy of

tissue microarray

technology, Image

analysis, and tumor

biobanking

Surinder K. BATRA, Ph.D.

Professor &Chairman Department of Biochemistry and

Molecular Biology, College of Medicine, Stokes-

Shackelford Professor, Associate Director for Education

and Training, Fred & Pamela Buffett Cancer Center,

Eppley Institute for Research in Cancer

University of Nebraska medical center

Omaha, NE

Email:[email protected]

Tumor-associated genes;

cancer diagnostics, cancer

vaccines; monoclonal

antibodies, genetic

engineering of antibodies

Kapil N. BHALLA, M.D., F.A.C.P.

Professor, Department of Leukemia, Division of Cancer

Medicine

The University of Texas MD Anderson Cancer Center,

Houston, TX

[email protected]

Targeted Therapy for

AML Stem Cells

Raju S. CHAGANTI, Ph.D. (Harvard University)

William E. Snee Chair at the Memorial Sloan-Kettering

Cancer Center

Department of Medicine and Cell Biology Program

Professor, Gernster Sloan- Kettering Graduate School of

Biomedical Sciences at Weill-Cornell Graduate School of

Medicine

Memorial Sloan-Kettering Cancer Center

New York, NY 10065


Understanding the natural

history of genomic

instability in cancer cells

and its implication to

clinical behavior of tumors

on the one hand, and to

normal cellular

developmental pathways

on the other.

Subhash CHAKRABARTY, Ph.D.

Professor

Depart. of Microbiology, Immunology & Cell Biology

Simmons Cooper Cancer Institute

Southern Illinois University School of Medicine

Springfield, Illinois 62794‐9677

[email protected]

Mechanisms of growth and

differentiation control in

epithelial cancer.

Dhrubajyoti CHAKRAVARTI, Ph.D.

Chief Scientist

4115 Harrison St, Bellevue, NE 68147

[email protected]

Website: http://www.life-120.com/

Research Interests:

Identify and develop

natural and synthetic

compounds that provide

protection against

environmental pollution.

Hobbies: Photography

Dhyan CHANDRA, Ph.D. (JNU, India)

Associate Professor

Dept. of Pharmacology & Therapeutics

Roswell Park Cancer Institute,

Elm & Carlton Streets,

Buffalo, NY14263

[email protected]

Research Interest:

Apoptosis signaling,

cancer stem cells

Subhash C. CHAUHAN, Ph.D.

Professor of Pharmaceutical Sciences

Professor of Pathology

University of Tennessee Health Science Center

Memphis, TN 38163


Develop molecular

markers for early cancer

diagnosis and targeted

therapy for cancer

treatment; elucidate the

regulatory mechanisms of

cell-cell adhesion and anti-

adhesion molecules that

cause cancers.

Dibash K. DAS, M.A., M.Phil., Ph.D. candidate Graduate Student

CUNY Hunter College & Weill Cornell Medicine

Brooklyn, NY 11214

E-mail: [email protected];

[email protected]

Molecular, cellular and

developmental biology

Gokul DAS, Ph.D.

Associate Professor of Oncology

Department of Pharmacology and Therapeutics

Member, Molecular Pharmacology and Cancer

Therapeutics Graduate Program

Co-Director, Breast Disease Site Research Group (DSRG)

Roswell Park Cancer Institute

Elm & Carlton Streets

Buffalo, NY14263

[email protected]

Interaction between

estrogen receptors and

tumor suppressor protein

p53 signaling in breast

cancer: understanding

molecular mechanisms and

identifying new prognostic

markers and therapeutic

targets;

Role of p53 and estrogen

receptor beta in non-small

cell lung cancer (NSCLC)

pathology;

Estrogen receptors and p53

in the regulation of

nuclear-mitochondrial

communication and energy

metabolism;

Clinical trials to translate

research findings from the

laboratory

Bakul I. DALAL, M.D., FRCP

Hematopathologist

Vancouver General Hospital

Clinical Professor, University of British Columbia

Vancouver Coastal Health

11Th Floor 601 West Broadway

Vancouver, British Columbia V5Z 4C2

Canada

Mail: [email protected]

Hematopathology

Gaga DEEP, Ph.D.

Associate Professor, Cancer Biology

Redox Biology & Medicine Ctr.

Wake Forest Baptist Medical Center, Hanes 5048

Winston-Salem, NC 27157


Silibinin; Prostatic

Neoplasms; Antioxidants;

Apoptosis; Antineoplastic

Agents; exosomes, health

disparity &

chemoprevention research

Animesh DHAR, Ph.D. Associate Professor, Cancer Biology

University of Kansas Medical Center

Kansas City, KS 66160


Prevention and treatment

for pancreatic cancer using

crocetin compound derived

from saffron, a spice and

food colorant present in

the dry stigmas of the plant

Crocus sativas L.;

developing a novel

crocetin compound for

therapeutic against

pancreatic cancer.

Chandradhar DWIVEDI, Ph.D. (Lucknow University)

(Retired)

Distinguished Professor and Head,

Department of Pharmaceutical Sciences

College of Pharmacy, South Dakota State University,

Brookings, SD 57007

[email protected]

RamaS.DWIVEDI, Ph.D.

Northwestern University

Chicago, IL

[email protected]

Himabindu GADDIPATI, M.D., EMTM

CEO & Founder

Elixsys Inc.

San Diego, CA 92120


Sanjiv Sam GAMBHIR, M.D., Ph.D.

Virginia and D.K. Ludwig Professor for Clinical

Investigation in Cancer Research

Chair, Department of Radiology

Stanford University School of Medicine

Stanford, CA

[email protected]

Varsha GANDHI, Ph.D.

Professor

Department of Experimental Therapeutics

UT M.D. Anderson Cancer Center

1515 Holcombe Blvd., Houston, TX 77030

[email protected]

(Lucknow University)-

Department of Pharmaceutical Sciences

College of Pharmacy, South Dakota State University,

Research Interest- Cancer

prevention and treatment

Hobbies- Reading,

spirituality, listening to

music, gardening

Himabindu GADDIPATI, M.D., EMTM Medical Oncology,

Medical Genetics

, M.D., Ph.D.

Virginia and D.K. Ludwig Professor for Clinical

Stanford University School of Medicine

Radiology/Nuclear

Medicine; developing

imaging assays to monitor

fundamental

cellular/molecular events

in patients; positron

emission tomography

(PET), optical

(fluorescence,

bioluminescence, Raman),

ultrasound, and

photoacoustic imaging are

focus of investigation

Therapeutics

1515 Holcombe Blvd., Houston, TX 77030

Experimental

therapeutics;use of

nucleoside analogues in

combination for therapy of

cancer on the basis of

biochemical rationale;

understanding the

biological, biochemical,

and molecular mechanisms

of action of each drug and

the consequences on the

metabolic events in intact

cells and in cell free

system.

Aniruddha GANGULY, Ph.D.

National Cancer Institute

Bethesda, MD

Former faculty, Harvard Medical School, Boston, MA

[email protected]

Ramesh GANJU, Ph.D.

Scott Endowed Chair and Professor

Vice Chair, Experimental Pathology

Ohio State University Medical Center

810 Biomedical Research Tower

460 West 12th Avenue

Columbus, OH 43210

[email protected]

Rita GHOSH, Ph.D.

Associate Professor

Department of Urology

The University of Texas Health Science Center at San

Antonio

7703 Floyd Curl Drive, Mail Code 7845

San Antonio, Texas 78229-3900

Phone: (210) 567-5664

[email protected]

Rayudu GOPALKRISHNA, Ph.D.

Associate Professor of Integrative & Anatomical Sciences

Cell and Neurobiology

Keck School of Medicine

University of Southern California

Health Sciences Center

Los Angeles, CA 90089-9112

[email protected] Sushovan GUHA, M.D., Ph.D.

Gastroenterologist

Houston, TX 77030

Phone: (713) 704-4000


Rishab K. GUPTA, Ph.D. (Retired)

Wayne Cancer Institute, CA

[email protected]

Harvard Medical School, Boston, MA

Mechanisms of tumor

development & metastasis,

tumor microenvironment,

brain tumor biology,

cancer diagnostics,

molecular analysis

technologies for cancer

research, informatics

technology in cancer

research, exosomal RNA

in cancer and cancer

diagnosis

Role of chemokines, and

various inflammatory

molecules, and anti-

inflammatory molecules,

in pathogenesis of various

diseases

The University of Texas Health Science Center at San

Mail Code 7845

Study on deregulation of

DNA damage signaling

and cell cycle progression

in cancer and use these

pathways as molecular

targets to develop

strategies for cancer

prevention and or therapy

of Integrative & Anatomical Sciences

Prostate cancer prevention

Research Interests: Novel

signal transduction

pathways in GI cancers

and chemoprevention of

GI cancer

Shanker L. GUPTA, Ph.D.

Program Manager

Developmental Therapeutics Program

Division of Cancer Treatment and Diagnosis

National Cancer Institute

Bethesda, MD

[email protected]

Anti-cancer drug

development

Sudhir GUPTA, M.D., Ph.D.

Professor, University of California, Irvine, CA

Institute of Immunology, UC Irvine

UC Irvine Healthcare

Irvine, CA

[email protected]

Molecular signaling in

apoptosis

Memory CD4+ and CD8+

T cells

Dendritic cell functions

Surendra GUPTA, Ph.D.

President

American Radiolabeled Chemicals, Inc.

Email: [email protected]

Website: www.arc-inc.com

Radiopharmaceuticals

Abid HUSSAIN, Ph.D.

Rakesh K. JAIN, Ph.D. Andrew Werk Cook Professor of Tumor Biology

(Radiation Oncology)

Director, Edwin L. Steele Laboratory for Tumor Biology,

Massachusetts General Hospital &

Harvard Medical School, Boston, MA


The research goal is to

understand the role of the

tumor microenvironment,

including the tumor

vasculature and matrix, in

tumor growth and response

to therapy, to develop

novel strategies to

manipulate the tumor

microenvironment, and to

translate these strategies

into improved cancer

detection, prevention and

treatment in humans.

Maneesh JAIN, Ph.D., IMTECH

Associate professor

Biochemistry & Molecular Biology


Omaha, NE


Development of

diagnostics & therapeutics

against cancer and allied

diseases; improving

delivery of antibody-based

therapeutic agents in solid

tumors by altering the

design of the antibodies

and modulating tumor

microenvironment by

'tumor-selective' agents.

H.N. JAYARAM, Ph.D.

Professor

Indiana University, IN

[email protected]

Madhavi KADAKIA, Ph.D.

Chair & Professor, Biochemistry & Molecular Biology

Dept. of Biochemistry & Molecular Biology

Wright State University

Dayton, OH 45435

[email protected]

Deciphering the signaling

pathways regulated by p63

and its role in cancer and

development.

Krishna Rani KALARI, Ph.D.

Assistant Professor, Biomedical Informatics

Mayo clinic

Rochester, MN


Development of novel

systems pharmacology

approaches to investigate

cancer genomics;

development of algorithms

and application of

computational methods to

identify pathways

associated with cancer and

variation to drug response

phenotypes.

Siva K. KOLLURI, Ph.D.

Associate Professor

Agricultural & Life Sciences

Oregon State University

Corvallis, OR


Discovering molecular

targets that are selective

for cancer, developing

agents that are selectively

toxic to cancer cells, and

devising optimal

combinations of

therapeutic agents aimed at

different molecular

pathways for the


of cancer; understanding

the role of PER-ARNT-

SIM (PAS) homology-

domain proteins in

carcinogenesis and

developing small

molecules to treat Bcl-2

overexpressing cancers.

Hari KAUL, Ph.D., FACN

Carroll W. Feist Endowed Chair

Professor & Chairman

Department of Biochemistry & Molecular Biology

School of Medicine LSUHSC- shreverport, LA

Associate Director, Feist Weiller Cancer Center

Phone (office):318-675-5161

[email protected]

Dr. Meena KATDARE, Ph.D. (University ofPune,

India, 1978)

Professor and Scientific Director

Hampton University Skin of Color Research Institute

(HUSCRI)

Hampton University

Hampton, VA

Ph: 212-746-5431

[email protected]

Identification of

fundamental molecular

mechanisms responsible

for initiation, promotion

and progression of breast,

colon, prostate, thyroid

and skin cancers;

molecular mechanisms

responsible for efficacious


of cancers by

phytochemicals present in

fruits, vegetables, grains,

spices, etc.

Hobbies: Gardening,

Interior Decoration,

Knitting, Dress designing,

Travel, Indian Music

Dr. Koyamangalath KRISHNAN, MD, FRCP, FACP Dishner Endowed Chair of Excellence in Medicine

Professor of Medicine

Division Chief of Hematology/Oncology

Department of Clinical Cancer Prevention, Division of

Cancer Prevention and Population Sciences,

The UT MD Anderson Cancer Center, Houston, TX

77030

[email protected]

Raju KUCHERLAPATI, Ph.D. Paul C. Cabot Professor, Department of Genetics,

Harvard Medical School

Professor, Department of Medicine

Scientific Director, Harvard-Partners Center for Genetics

and Genomics, Partners HealthCare System, Brigham and

Women's Hospital

Boston, MA

[email protected]

Cloning and

characterization of human

disease genes with a focus

on human syndromes with

a significant

cardiovascular

involvement; use of

genetic/genomic

approaches to understand

the biology of cancer and

the generation and

characterization of

genetically modified

mouse models for cancer

and other human disorders.

Deepak KUMAR, Ph.D.

Professor of Pharmaceutical Sciences

Director

Julius L. Chambers Biomedical/Biotechnology Research

Institute

North Carolina Central University

Durham, NC 27707


Characterize molecular

mechanisms of cancer

progression emphasizing

the role of microRNAs in

prostate cancer disparities;

characterize molecular

targets for therapeutic and

diagnostic interventions in

cancer precision medicine;

microRNA biology and

their role as biomarkers

and therapeutic target.

Rakesh KUMAR, Ph.D.

Professor

Biochemistry and Molecular Biology

George Washington University School of Medicine

Washington, DC


Shaji KUMAR, M.D.

Associate Professor

Mayo Clinic, Rochester, MN 55905

[email protected]

Research Interests:

Interactions between

malignant plasma cells

and the marrow

microenvironment in

plasma cell malignancies;

develop new therapeutic

approaches to target these

interactions and enhance

the efficacy of the

currently available

therapies.

Rekula R. MANEPALLI, Ph.D. University of Kansas Medical Center



Aroop MANGALIK, M.D. (Retired)

Hematology

900 Camino de Salud NE

University of New Mexico

Albuquerque, NM 87131

Ph. 505-272-3120

Hematology Oncology

Kapil MEHTA, Ph.D. (PGI, Chandigarh, India)

Director R&D, Molecular Quest-Personalized Medicine

Formerly,Professor of Cancer Medicine (Biochemistry)

University of Texas M. D. Anderson Cancer Center

Houston, TX 77030


Research interests:

Chemoresistance,

metastasis,

retinoids, drug delivery

systems

Hobbies: Reading,

gardening, music

Rajendra G. MEHTA, Ph.D.

Assistant Vice President, Professor and Head

IIT Research Institute and IIT

Chicago, IL 60616

[email protected]

Research Interests:

Efficacy and molecular

mechanism(s) of action of

chemopreventive

agents including Vitamin

D and Resveratrol in

breast, colon and lung

cancer models.

Krishna MENON, Ph.D.

Scientist/Business owner

Cell Centix Inc.

Beverly, MA

[email protected]

In vivo and vitro

preclinical testing

Lopa MISHRA, M.D., FAASLD

Director, Center for Translational Medicine

Department of Surgery

George Washington University

Washington, DC 20016


Gastroenterology;

diagnosis and treatment of

diseases of the digestive

tract and liver with a

substantial focus on

cancers

Sankar MITRA, Ph.D.

Full Member, Professor of Radiation Oncology, Institute

for Academic Medicine

Houston Methodist Research Institute

Houston, TX

[email protected]

Genome damage, its

repair, and its influence in

carcinogenesis and cancer

therapy; recent research

focus is on enhancement of

chemo/radiation sensitivity

of tumor cells using

targeted DNA repair

inhibitors; following his

early studies with MGMT

inhibition, his current

research aims to identify

inhibitors for repair

pathways for

oxidative/radiation damage

Debasish MONDAL, Ph.D.

Associate Professor

Department of Pharmacology

Tulane University

New Orleans, LA

[email protected]

HIV-1 induced

pathogenesis; role of HIV-

1 transactivator (Tat)

protein in regulating viral

latency and infectivity;

pharmacological

interventions to enhance

efficacy and reduce toxic

side effects of anti-

retroviral drugs

Hasan MUKHTAR, Ph.D.

Professor

Department of Dermatology

University of Wisconsin

School of Medicine & Public Health

Madison, WI

[email protected]

Molecular target based

approaches for prevention

and treatment of cancer

and skin disease psoriasis

by phytochemicals

Anuradha MURALI, Ph.D., MSCR

Clinical Trial Manager, Gastroenterology

Microbiology and Immunology

Medical University of South Carolina

Charleston, USA

[email protected]

Harikrishna NAKSHATRI, Ph.D.

Marian J. Morrison Professor of Surgery

Indiana University School of Medicine

Indianapolis, IN

[email protected]

Activation of NF-kB in

estrogen receptor negative

breast cancer. The focus is

on genomic aspects of

anti-estrogen resistance,

mechanisms of organ-

specific metastasis and

biomarkers of breast

cancer progression and

therapeutic response

Pratima NANGIA-MAKKER, Ph.D. Assistant Professor

Karmanos Cancer Institute

Wayne State University, Detroit, MI 48201

[email protected]

Research Interests: Role

of carbohydrate-binding

protein galectin-3 in breast

cancer progression and

metastasis. We are also

studying the inhibitory

effects of natural plant

products on cancer

progression

Satyabrata NANDI, Ph.D. (Retired)

Professor Emeritus of Cell & Developmental Biology

University of California, Berkeley, CA

[email protected]

Determine the biological

and molecular bases for

susceptibility and

resistance to breast

carcinogenesis as well as

for the prevention of breast

cancer

Shanker NAYAK, Ph.D. (Diseased)

Director, Diagnostics

Hoag Cancer Center

New Port Beach, CA

Gene vaccine therapy,

Preclinical cancer research

Akhilesh PANDEY, M.D., Ph.D. Professor of biological chemistry, oncology and pathology

Johns Hopkins University School of Medicine

Professor of molecular microbiology and immunology

Johns Hopkins Bloomberg School of Public Health

Baltimore, MD 21205


Comparative genomics;

Bioinformatics and

biological databases and

annotation; Mass

spectrometry and

proteomics;

Phosphorylation and

analysis of signal

transduction pathways

Arokya Mary S. PAPU JOHN, Ph.D. Postdoctoral Research Associate

Biomedical & Diagnostic Sciences

University of Tennessee

Knoxville, TN

[email protected]

Cancer Diagnostics

Tushar PATEL, M.B., Ch.B.

Professor of Medicine

Department of Transplantation

James C. and Sara K. Kennedy Dean for Research

Mayo Clinic

Jacksonville, FL

[email protected]

Transplantation

medicine;focuses on liver

epithelial cell biology,

with an emphasis on

understanding the role and

regulation of noncoding

RNA genes in the

pathogenesis of liver and

biliary tract cancers;

particularly interested in

roles of extracellular

vesicles and extracellular

RNA in fundamental

processes involved in liver

cancers.

Sen PATHAK, Ph.D. (Retired)

Former Professor

Cytogenetics

MD Anderson cancer Center

Houston, TX

[email protected]

Cancer cytogenetics

Subbarayan R POCHI, Ph.D. (Banaras Hindu

University, 1994)

Research Assistant Professor

Department of Medicine

Division of Hematology and Oncology

University of Miami Miller School of Medicine

Miami, FL - 33176

Research Interests: 5FU

resistance,

Pharmocogenomics,

Ethnic botanicals

Hobbies: Reading,

Traveling by road,

Community work.

Raj PURI, M.D., Ph.D.

Division Director, Food and Drug Administration,

Bethesda, MD

[email protected]

Govind RAGUPATHI, Ph.D.

Associate Attending Immunologist

Memorial Sloan-Kettering Cancer Center

New York, NY 10065

Tel: (646) 888 2363

Fax: (646) 422 0516


Develop monoclonal

antibodies, optimize

vaccines that induce

antibody responses, and

produce and test new

immunological adjuvants

to augment these responses

Ranju RALHAN, Ph.D.

Department of Pathology and Laboratory Medicine

Joseph & Wolf Lebovic Health Complex

Mt. Sinai Hospital

600 University Ave., Room 6-416

Toronto, ON M5G 1X5

[email protected]

Translational cancer

research, molecular

diagnostics proteomics,

genomics, epigenomics,

cancer biology, cell

biology, targeted therapy

Chandra RAMANATHAN, Ph.D., MBA

Scientist, Head Early Pipeline Oncology

Bayer HealthCare Pharmaceuticals

West Haven, Connecticut 06516

[email protected]

Aramandla RAMESH, Ph.D.

Associate Professor

Biochemistry & Cancer Biology

Meharry Medical College

Nashville, TN

[email protected]

Environmental

Toxicology, Chemical

Carcinogenesis

Pranela RAMESHWAR, Ph.D.

Professor

Department of Medicine

Division of Hematology-Oncology

Rutgers, The New Jersey Medical School

Newark, NJ

Telephone: (973) 972 0625

[email protected]

Cancer stem cell research;

breast cancer dormancy in

bone marrow; immune

protection of specific

breast cancer cell subsets

by mesenchymal stem

cells; neural-hematopoietic

axis

Kaladhar B. REDDY, Ph.D.

Professor

Wayne State University School of Medicine

540 East Canfield Avenue

Detroit, MI 48201


Novel strategies for

treatment and prognosis of

breast cancer by

combining experimental

therapeutics with cell

biology; cancer stem cells

E. Premkumar REDDY, Ph.D.

Professor of Pharmacological Sciences & Oncological

Sciences, Icahn School of Medicine at Mount Sinai, NY

Formerly, Director of the Fels Institute for Cancer

Research and Molecular Biology, Temple University

School of Medicine, Philadelphia


Pioneered the development

of small molecule

inhibitors targeted against

oncogenes and cell cycle

regulators for cancer

therapy; developed six

different cancer drugs, two

of which (ON013100, and

ON01210) have entered

clinical trials.

Shrikanth REDDY, Ph.D.

Department of GI Med Oncology

MD Anderson Cancer Center

1515 Holcombe Blvd

Box 0956

Houston, TX 77030

[email protected]

Fazlul SARKAR, Ph.D.

Formerly, Distinguished Professor

Department of Pathology

Karmanos Cancer Institute

Detroit, MI

[email protected]

Role of NF-κB and its

signaling molecules in

solid tumors, and in

elucidating the molecular

mechanisms of action of

“natural agents” for cancer

prevention and therapy

Rajeev S. SAMANT, Ph.D. Associate Professor


University of Alabama at Birmingham

Birmingham, AL 35233


Identification and

characterization of novel

modulators of

developmental signaling

involved in tumor

progression and

metastasis; to identify and

understand the functional

contributions of unique

transcriptional,

translational and

epigenetic changes which

affect tumor invasion,

epithelial-mesenchymal-

transition (EMT),

developmental signaling

(Wnt, Hedgehog and

TGFβ) and crosstalk of

tumor cells with the tumor

microenvironment.

Lalita SHEVDE-SAMANT, Ph.D. Associate Professor


Director, Cancer Biology Theme

Associate Director for Education & Training, UAB

Comprehensive Cancer Center

University of Alabama at Birmingham

Birmingham, AL 35233

E-mail:[email protected]

Understanding the

aberrations intrinsic to the

tumor cells and those that

are extrinsically

manipulated as a result of

interaction with cells in the

tumor microenvironment.

D. S. R. SARMA (Retired), Ph.D.

Former Professor

University of Toronto, Canada

[email protected]

Gangadhara REDDY SAREDDY, Ph.D. Postdoctoral Fellow

The University of Texas health Sciences Center at San

Antonio

San Antonio, TX 78229


Tumor biology

Dipak K. SARKAR, Ph.D. (Calcutta), D.Phil. (Oxford) Distinguished professor

Director - Endocrine Program

Endocrine Research Facility

Rutgers University

New Brunswick, NJ 08901

E-Mail: [email protected]


http://endocrine.rutgers.edu

Understanding how stress

promotes infection,

cancers and alcohol-related

diseases using the

laboratory rodent as an

animal model; evaluating

the feasibility of cell

therapy, gene therapy and

tissue-targeted transgenic

procedures to understand

and prevent stress

problems and cancers in

normal and alcoholic

patients.

Anjana SAXENA, Ph.D.

Associate Professor-Biology

Brooklyn College

City University of New York, NY

Phone: 718.951.5000 x2671

Email:[email protected]

Studies nucleolar stress

factors (NSFs) and their

role/s in regulating cell

cycle under normal

conditions and during

cellular responses to DNA

damage.

Neeraj SAXENA, Ph.D.

National Cancer Institute, Bethesda, MD

Formerly, University of Maryland School of Medicine

Baltimore, MD

[email protected]

Links between obesity,

adipocytokines and

carcinogenesis

Senthamil SELVAN, Ph.D. Vice-President R&D

Omni Array Biotechnology

15601 Crabbs Branch Way

Rockville, MD

[email protected]

Cancer Immunotherapy

Subrata SEN, Ph.D.

Professor &Deputy Chair, Department of Translational

Molecular Pathology, Division of Pathology/Lab

Medicine, The University of Texas MD Anderson Cancer

Center, Houston, TX

Phone: (713) 834-6040


Functional characterization

of the genes regulating

mitotic chromosome

segregation and

elucidation of their role in

the induction of

chromosomal instability in

cancer

Dawn C. SEQUEIRA, J.D.

Immigration Attorney

Legacy Immigration

10411 Motor City Dr., Suite 750

Bethesda, MD 20817

Phone: 301-917-9282


Specialized in immigration

law. Legacy Immigration,

L.L.C. was established

upon the belief that every

hard-working person

deserves freedom, the

opportunity for prosperity

and success, and an

upward social mobility for

his or her family.

Shyam SHARAN, Ph.D.

Deputy Program Director, Mouse Cancer

Senior Investigator

Head, Genetics of Cancer Susceptibility Section

Center for Cancer Research

National Cancer Institute, Frederick, MD

[email protected]

Dipali SHARMA, Ph.D. Associate Professor of Oncology

Kimmel Cancer Center

Johns Hopkins University

Baltimore, MD

[email protected]

Jagannadha K. SASTRY, Ph.D.

Professor

Department of Immunology

The University of Texas MD Anderson Cancer

Houston, TX

E-mail:

Zahid H. SIDDIK, Ph.D.

Professor of Medicine (Pharmacology)

Department of Experimental Therapeutics, Division of

Cancer Medicine

UTMD Anderson Cancer Center

Houston, TX

[email protected]

Garima SINHA

Graduate Student

Rutgers Biomedical Health Sciences

Rutgers, The State University of New Jersey

Newark, NJ

[email protected]

Mouse Cancer Genetics Prog.

Head, Genetics of Cancer Susceptibility Section

Frederick, MD

DNA repair, hereditary

Breast cancer, tumor

suppressor, mouse models,

recombineering, BRCA1/2

variants

Breast Cancer, Obesity-

Cancer Connection,

Adipocytokines,

Metastasis, Tamoxifen

Resistance, Novel

Therapeutics, Bioactive

Food Components,

Signaling Mechanisms

Texas MD Anderson Cancer Center

Understanding the biology,

pathology and genetics of

two viral diseases

impacting human health;

HPV-associated cancers

and HIV-induced AIDS;

develop procedures and

reagents for prediction,

treatment as well as

prevention.

Department of Experimental Therapeutics, Division of

Understanding how drug

resistance is induced when

wild-type p53 is present

and how such a

mechanism can be

circumvented through drug

design; dysfunctionality of

the p53/p21 pathway and

how it impacts apoptosis

through loss of checkpoint

response.

rs, The State University of New Jersey

Cancer stem cell research;

intercellular

communication in cancer

stem cells

Ajay P. SINGH, Ph.D. Professor of Oncologic Sciences

University of South Alabama Mitchell Cancer Institute

Mobile, AL 36004


Cancer progression and

metastasis, therapeutic

resistance in cancer,

tumor-stromal

interactions, molecular

bases of cancer health

disparities, microRNAs

in cancer, molecular

diagnosis, prognosis and

sub-classification of

cancer, natural products

as cancer prevention and

therapy agents.

Promila SINGH, Ph.D.

Professor

Department of Biochemistry & Molecular Biology

University of Texas Medical Branch

Galveston, TX

[email protected]

Shivendra V. SINGH, Ph.D.

Department of Pharmacology & Chemical biology

Professor& Chair in Cancer Prevention Research

University of Pittsburgh Medical Center

Pittsburgh, PA 15090


Cancer Pharmacology,

Drug Discovery,

Signal Transduction

Sujay SINGH, Ph.D.

President and CEO

ABGENEX Corp.

San Diego, CA

[email protected]

Cancer diagnostics,

Biotechnology

development

Keshav K. SINGH, Ph.D.

Professor of Oncology


Buffalo, NY, 14263

www.keshavsingh.org

Research Interest: Role

of mitochondria in

cancer, Inter genomic

crosstalk and its role

tumorigenesis and mitochondrialdiseases

Hobbies: Kite flying,

traveling

Shailesh SINGH, Ph.D. Professor

Microbiology, Biochemistry & Immunology

Morehouse School of Medicine

Atlanta, GA 30127

Phone: 404-756-5718


Developing

comprehensive

treatment/prevention

strategies for prostate,

breast and ovarian cancer.

These strategies are

directed to tumor cells

and/or immune system

using natural and synthetic

products as a single agent

or in combination with

conventional therapeutics.

Shaneen M. SINGH, Ph.D. Associate Professor

Brooklyn Collage

City University of New York

Brooklyn, NY 11210


Application of

computational approaches

to gain insight into cellular

signal transduction

pathways; normal and

aberrant functioning of

domains contained in

proteins that function in a

variety of biological

processes.

Raghu SINHA, Ph.D. (PGIMER, Chandigarh, India)

Associate Professor

Penn State College of Medicine, Hershey, Pennsylvania

Website link:

http://fred.psu.edu/ds/retrieve/fred/investigator/rus15

[email protected]

Research Interests: Breast

cancer model systems,

molecular mechanisms of

prevention in breast and

prostate cancers.

Taduru SREENATH, Ph.D.

Assistant Director, CPDR Basic Science Research

Program,

The Henry M. Jackson Foundation

Research Assistant Professor of Surgery

USUHS

[email protected]

Scientific interests focus

on understanding

molecular mechanisms

underlying prostate cancer

initiation and development

using mouse models

Saraswati SUKUMAR, Ph.D.

Barbara B. Rubenstein Professor of Oncology

Johns Hopkins University School of Medicine, Baltimore,

MD21231

[email protected]

Research Interests:

Discovery and study of

molecular alterations in

breast cancer. Methods and

markers for early detection

and prognosis. Rajeshwar Rao TEKMAL, Ph.D.

Carl J. Pauerstein Professor in Reproductive Research,

Director, Division of Reproductive Research

Department of Obstetrics and Gynecology

University of Texas Health Science Center at San Antonio

San Antonio, TX 78229-3900

Tel: 210-567-4930; Direct: 210-567-4935

[email protected]

Role of hormones

and growth factors and

their receptors in the

initiation and progression

of breast,

cervical and ovarian

cancers.

Nit Anand T. TELANG, Ph.D.


Buffalo, NY

[email protected]

T. J. THOMAS, Ph.D.

Professor

R.W. Johnson Medical Center

Rutgers University, NJ

[email protected]

[email protected]

Develop novel DNA

delivery vehicles for gene

therapy. The current focus

is on breast cancer

Sufi THOMAS, Ph.D.

Associate professor

University of Kansas medical Center



Specializes in head and

neck cancer translational

research, developed

several therapeutic

approaches that have been

tested in clinical trials;

delineating the mechanism

where by the tumor

microenvironment and in

particular tumor-associated

fibroblasts facilitate head

and neck cancer

progression and response

to therapy.

Meghana TRIVEDI, Ph.D.

Associate Professor

Department of Pharmacological and Pharmaceutical

Sciences

University of Houston College of Pharmacy

Texas Medical Center Campus

Houston, Texas 77030

Ph. 832-842-8335 [email protected]

G-protein coupled receptor

targets in cancer treatment;

drug discovery for novel

targets and test drug

efficacy to predict

treatment outcomes;

cellular signaling of

proteins targeted by drugs;

identification of genetic,

cellular, and circulating

biomarkers to predict

outcome of

pharmacological treatment

in cancer patients.

Shahid UMAR, Ph.D.

Associate Professor

Director of Gastrointestinal Research

University of Kansas Medical center

Kansas City, Kansas

P: 913-945-6337

[email protected]

Research Focus: Role of

bacterial infection in

colonic crypt hyperplasia

and/or inflammation

and/or cancer. Specific

research areas include: (a)

Regulation of cross-talk

between components of

the Wnt/b-catenin and

Notch and NF-kB and

Notch pathways relative to

inter-relationship amongst

cell proliferation,

inflammation and cancer;

(b) Cancer Stem Cells, and

(c) mechanism(s) of

chemoprevention by

dietary factors and its

novel derivatives.

Ratna K. VADLAMUDI, Ph.D.

Professor

Department of Obstetrics & Gynecology

UTHSCSA, San Antonio, TX

[email protected]

Ph. (210) 567-4930

Research Interests:

Estrogen signaling,

Hormonal therapy

resistance, Nuclear

receptors, Signal

transduction, Tg/KO

mouse models for cancer

Hariprasad VANKAYALAPATI, Ph.D., M.Pharm.

Assistant Professor&Chief Scientist of Medicinal

Chemistry

Center for Investigational Therapeutics (CIT)

The Huntsman Cancer Institute (HCI) & School of

Medicine

University of Utah in Salt Lake City

Salt Lake City, UT


[email protected]

[email protected]

Medicinal/Organic/Compu

tational Chemistry

capabilities and successful

execution of translational

research in search for

novel cancer therapeutics;

target validation,

druggability and early

discovery to IND stage of

development of novel

cancer therapeutics.

Sooryanarayana VARAMBALLY, Ph.D.

Associate Professor

Director of Integrative Translational Oncologic Pathology

Research

Co-Director of the Graduate Biomedical Sciences (Cancer

Biology)


Wallace Tumor Institute, WTI-420B

The University of Alabama at Birmingham

1824 6th Avenue South

Birmingham, AL 35294-3300



http://ualcan.path.uab.edu/

Understanding the

molecular basis of cancers

using genomics,

proteomics, bioinformatics

and integrative approach.

Investigate the utility of

inhibitor for new

molecular targets by

experimental therapeutic

approach.

Atul VARADHACHARI, M.D.

President & Chief Operating Officer

Agennix, Inc., Houston, TX

[email protected]

HariKrishna VELLANKI, Ph.D.

Postdoctoral Fellow

Department of Surgery

Royal College of Surgeons in Ireland

Beaumont Hospital

Dublin 9

Ireland


Arti PATEL VARANASI, Ph.D., M.P.H.

President & CEO

Advancing Synergy, LLC

1450 South Rolling Road

Baltimore, MD 21227

www.advancingsynergy.com

[email protected]

Siva VENUGOPAL, Ph.D.

Sugar Land, TX

Engineering/bioinformatics company owner

[email protected]

Inder VERMA, Ph.D. Professor

Laboratory of Genetics

American Cancer Society Professor of

Irwin and Joan Jacobs Chair in Exemplary Life Science

The Salk Institute for Biological Studies

La Jolla, CA

[email protected]

Ajit K. VERMA, Ph.D. (Univ. of South Australia,

Adelaide)

Professor, University of Wisconsin

Madison, WI 53792

weblink: www.med.wisc.edu/metc/fac/fac53.php.


Suryavathi VISWANADHAPALLI, Ph.D.

Postdoctoral fellow

University of Texas Health Sciences Center at San

Antonio

San Antonio, TX 78229


Meena VORA, Ph.D.

Scientist/Business owner

Biosphare

Fremont, CA

Breast cancer biology,

tumor dormancy, stem cell

characterization

, Ph.D., M.P.H. Cancer research, public

health, advocacy, capacity

building and project

management

Engineering/bioinformatics company owner

American Cancer Society Professor of Molecular Biology

Irwin and Joan Jacobs Chair in Exemplary Life Science

The Salk Institute for Biological Studies

Gene therapy for cancer;

developed viruses for gene

therapy vectors;developed

a gene therapy vector,

based on a stripped-down

version of HIV, that can

deliver genes to non-

dividing cells, which

constitute majority of the

cells in our bodies.

of South Australia,

www.med.wisc.edu/metc/fac/fac53.php.

Research interests:

etiology and prevention of

skin and prostate cancer.

PKCepsilon signal

transduction pathways

Hobbies: fishing and

gardening.

Suryavathi VISWANADHAPALLI, Ph.D.

University of Texas Health Sciences Center at San

Demonstrated history of

working in the research

industry; skilled in PDX

models, Transgenic Mice,

Southern Blot, qPCR, and

Genetics.

[email protected]

Mansukh WANI, Ph.D. (Retired)

Principal Scientist

Research Triangle Institute, NC 27709

www.rti.org/naturalproducts

[email protected]

Research Interests:

Discovery of anticancer

agents of diverse natural

origin; discoverer of taxol,

camptothecin

Date post:	06-Aug-2020
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

Life Members · 1/9/2017 · Cancer Medicine and Immunology, The University of Texas M. D....

Documents